Parasitology Research

, Volume 112, Issue 4, pp 1475–1481 | Cite as

Antimalarial activities of medicinal plants and herbal formulations used in Thai traditional medicine

  • Artitaya Thiengsusuk
  • Wanna Chaijaroenkul
  • Kesara Na-BangchangEmail author
Original Paper


Malaria is one of the world's leading killer infectious diseases with high incidence and morbidity. The problem of multidrug-resistant Plasmodium falciparum has been aggravating particularly in Southeast Asia. Therefore, development of new potential antimalarial drugs is urgently required. The present study aimed to investigate antimalarial activities of a total of 27 medicinal plants and 5 herbal formulations used in Thai traditional medicine against chloroquine-resistant (K1) and chloroquine-sensitive (3D7) P. falciparum clones. Antimalarial activity of the ethanolic extracts of all plants/herbal formulations against K1 and 3D7 P. falciparum clones was assessed using SYBR Green I-based assay. All plants were initially screened at the concentration of 50 μg/ml to select the candidate plants that inhibited malaria growth by ≥50 %. Each candidate plant was further assessed for the IC50 value (concentration that inhibits malaria growth by 50 %) to select the potential plants. Selectivity index (SI) of each extract was determined from the IC50 ratio obtained from human renal epithelial cell and K1 or 3D7 P. falciparum clone. The ethanolic extracts from 19 medicinal plants/herbal formulation exhibited promising activity against both K1 and 3D7 clones of P. falciparum with survival of less than 50 % at the concentration of 50 μg/ml. Among these, the extracts from the eight medicinal plants (Plumbago indica Linn., Garcinia mangostana Linn., Dracaena loureiri Gagnep., Dioscorea membranacea Pierre., Artemisia annua Linn., Piper chaba Hunt., Myristica fragrans Houtt., Kaempferia galanga Linn.) and two herbal formulations (Benjakul Formulation 1 and Pra-Sa-Prao-Yhai Formulation) showed potent antimalarial activity with median range IC50 values of less than 10 μg/ml against K1 or 3D7 P. falciparum clone or both. All except G. mangostana Linn. and A. annua Linn. showed high selective antimalarial activity against both clones with SI > 10. Further studies on antimalarial activities in an animal model including molecular mechanisms of action of the isolated active moieties are required.


Artemisinin Antimalarial Drug Artesunate Antimalarial Activity Selectivity Index 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The study was supported by Thammasat University; The Commission on Higher Education, Ministry of Education of Thailand; and The National Research University Project of Thailand (NRU), Thailand Research Fund (TRF), Office of Higher Education Commission.


  1. Azebaze AG, Meyer M, Valentin A, Nguemfo EL, Fomum ZT, Nkengfack AE (2006) Prenylated xanthone derivatives with antiplasmodial activity from Allanblackia monticola STANER L.C. Chem Pharm Bull 54(1):111–113PubMedCrossRefGoogle Scholar
  2. Bennett TN, Paguio M, Gligorijevic B, Seudieu C, Kosar AD, Davidson E, Roepe PD (2004) Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrob Agents Chemother 48:1807–1810PubMedCrossRefGoogle Scholar
  3. Chu D, Miles H, Toney D, Ngyuen C, Marciano-Cabral F (1998) Amebicidal activity of plant extracts from Southeast Asia on Acanthamoeba spp. Parasitol Res 84(9):746–752PubMedCrossRefGoogle Scholar
  4. Connolly JD, Deans R, Haque ME (1995) Constituents of Piper chaba. Fitoterapia 66(2):188Google Scholar
  5. Durga R, Sridhar P, Polasa H (1990) Effects of plumbagin on antibiotic resistance in bacteria. Indian J Med Res 91:18–20PubMedGoogle Scholar
  6. Firestone GL, Sundar SN (2009) Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med 11:e32PubMedCrossRefGoogle Scholar
  7. Lambros C, Vanderberg JP (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65(3):418–420PubMedCrossRefGoogle Scholar
  8. Likhitwitayawuid K, Chanmahasathien W, Ruangrungsi N, Krungkrai J (1998a) Xanthones with antimalarial activity from Garcinia dulcis. Planta Med 64(3):281–282PubMedCrossRefGoogle Scholar
  9. Likhitwitayawuid K, Kaewamatawong R, Ruangrungsi N, Krungkrai J (1998b) Antimalarial naphthoquinones from Nepenthes thorelii. Plant Med 64(3):237–241CrossRefGoogle Scholar
  10. Likhitwitayawuid K, Sawasdee K, Kirtikara K (2002) Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri. Plant Med 68(9):841–843CrossRefGoogle Scholar
  11. Lin LC, Yang LL, Chou CJ (2003) Cytotoxic naphthoquinones and plumbagic acid glucosides from Plumbago zeylanica. Phytochemistry 62(4):619–622PubMedCrossRefGoogle Scholar
  12. Morita T, Jinno K, Kawagishi H, Arimoto Y, Suganuma H, Inakuma T, Sugiyama K (2003) Hepatoprotective effect of myristicin from nutmeg (Myristica fragrans) on lipopolysaccharide/d-galactosamine-induced liver injury. J Agric Food Chem 51(6):1560–1565PubMedCrossRefGoogle Scholar
  13. Na-Bangchang K, Congpuong K (2007) Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand. Tohoku J Exp Med 211:99–113PubMedCrossRefGoogle Scholar
  14. Na-Bangchang K, Ruengweerayut R, Muhamad P, Chaijaroenkul W (2010) Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai–Myanmar border. Mal J 8:273–280Google Scholar
  15. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM (2008) Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359(24):2619–2620PubMedCrossRefGoogle Scholar
  16. Parimala R, Sachdanandam P (1993) Effect of plumbagin on some glucose metabolizing enzymes studied in rats in experimental hepatoma. Mol Cell Biochem 125(1):59–63PubMedCrossRefGoogle Scholar
  17. Rasoanaivo P, Deharo E, Urverg SR, Frappier F (2004) Guidelines for the nonclinical evaluation of the efficacy of traditional antimalarials. In: Willcox M, Rasoanaivo P, Bodeker G (eds) Traditional medicinal plants and malaria. CRC Press, Boca Raton, Chapter 16Google Scholar
  18. Riscoe M, Kelly JX, Winter R (2005) Xanthones as antimalarial agents: discovery, mode of action, and optimization. Curr Med Chem 12(21):2539–2549PubMedCrossRefGoogle Scholar
  19. Saekoo J, Graidist P, Leeanansaksiri W, Dechsukum C, Itharat A (2010) Dioscorealide B from the traditional Thai medicine Hua-Khao-Yen induces apoptosis in MCF-7 human breast cancer cells via modulation of Bax, Bak and Bcl-2 protein expression. Nat Prod Commun 5(12):1921–1926PubMedGoogle Scholar
  20. Schwikkard S, van Heerden F (2002) Antimalarial activity of plant metabolites. Nat Prod Rep 19(6):675–692PubMedCrossRefGoogle Scholar
  21. Sudhanshu S, Neerja P, Jain DC, Bhakuni RS (2003) Antimalarial agents from plant sources. Curr Sci 85(9):1314–1329Google Scholar
  22. Sugie S, Okamoto K, Rahman KM, Tanaka T, Kawai K, Yamahara J, Mori H (1998) Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett 127(1–2):177–183PubMedCrossRefGoogle Scholar
  23. Trager W, Jensen JB (1976) Human malaria culture parasite in continuous culture. Science 193:673–675PubMedCrossRefGoogle Scholar
  24. Wang YC, Huang TL (2005) High-performance liquid chromatography for quantification of plumbagin, an anti-Helicobacter pylori compound of Plumbago zeylanica L. J Chromatogr A 1094(1–2):99–104PubMedGoogle Scholar
  25. World Health Organisation (2006) Guidelines for the treatment of malaria. Geneva, WHO, HTM/MAL/110Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Artitaya Thiengsusuk
    • 1
  • Wanna Chaijaroenkul
    • 1
  • Kesara Na-Bangchang
    • 1
    Email author
  1. 1.Thailand Center of Excellence in Drug Discovery and Development (TCEDDD)Thammasat UniversityRangsitThailand

Personalised recommendations